Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus

Brain, Behavior, and Immunity

Volumn 25, Issue 2, 2011, Pages 279-285

  Ndhlovu, Mathias ^a,c   Preuß, Beate E ^a   Dengjel, Jörn ^a,d   Stevanovic, Stefan ^a   Weiner, Stefan M ^b   Klein, Reinhild ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c MARIENHOSPITAL STUTTGART   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

tubulin; Autoantibodies; Neuropsychiatric manifestations; Systemic lupus erythematosus

Indexed keywords

ALPHA TUBULIN; AUTOANTIGEN; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; ESCHERICHIA COLI; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; PRIORITY JOURNAL; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AUTOANTIGENS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CATTLE; CLONING, MOLECULAR; COLLAGEN DISEASES; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; MITOCHONDRIA; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBULIN; YOUNG ADULT;

EID: 78651432242     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.09.019     Document Type: Article

References (50)

1. Abbott N.J., Mendonca L.L., Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003, 12:908-915.
2. ACR Ad Hoc Committee on Neuropsychiatric Lupus nomenclature The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42:599-608.
3. Agmon-Levin N., Gilburd B., Kivity S., Katz B.S.P., Flitman-Katzevman I., Shoenfeld N., Paran D., Langevitz P., Shoenfeld Y. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. Isr. Med. Ass. J. 2009, 11:403-406.
4. Barth H., Klein K., Börtlein A., Guseo A., Berg P.A., Wiethölter H., Klein R. Analysis of immuno regulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced TH1, relapsing-remitting course with enhanced TH2 reactivity. J. Neuroimmunol. 2002, 133:175-183.
5. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992, 35:630-640.
6. Bonfa E., Golombek S.J., Kaufman L.D., Skelly S., Weissbach H., Brot N., Elkon K.B. Association between lupus psychosis and anti-ribosomal P protein antibodies. Arthritis Rheum. 1987, 317:265-271.
7. Carré M., André N., Carles G., Borghi H., Brichese L., Briand C., Braguer D. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J. Biol. Chem. 2002, 277:33664-33669.
8. Colasanti T., Delunardo F., Margutti P., Vacirca D., Piro E., Siracusano A., Ortona E. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus. J. Neuroimmunol. 2009, 212:3-9.
9. Connolly A.M., Pestronk A. Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies. J. Infect. Dis. 1997, 176:S157-S159.
10. Correale J., Villa A. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity 2007, 40:148-160.
11. Danon V.L., Garty B.Z. Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. Neuropediatrics 1986, 17:23-27.
12. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-SNA Abs cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 2001, 7:1189-1193.
13. Dengjel J., Rammensee H.G., Stevanovic S. Glycan side chains on naturally presented MHC class II ligands. J. Mass Sepctrom. 2005, 40:100-104.
14. Ebert T., Chapman J., Shoenfeld Y. Anti-ribosomal P protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus 2005, 14:571-575.
15. Fragoso-Loyo, H., Cabiedes, J., Orozco-Narváez, A., Dávila-Maldonado, L., Atisha-Fregoso, Y., Biamond, B., Llorente, L., Sánchez-Guerro, J., 2008. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implicationds for diagnosis and pathogenesis. PLoS one 3, e3347. doi: 10.1371/journal.pone.0003347.
16. Greenwood D.L., Gitlis V.M., Alferuccio F., Sentry J.W., Toh B.H. Autoantibodies in neuropsychiatric lupus. Autoimmunity 2002, 35:79-86.
17. Haddouk S., Marzouk S., Jallouli M., Fourati H., Frigui M., Hmida Y.B.H., Koubaa F., Sellami W., Baklouti S., Hachicha J., Bahloul Z., Masmoudi H. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology 2009, 48:953-957.
18. Hanly J.G. Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 2005, 31:273-298.
19. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. USA 2006, 103:678-683.
20. Huizinga T.W.J., Diamond B. Lupus and the central nervous system. Lupus 2008, 17:376-379.
21. Jaglin X.H., Chelly J. Tubulin-related cortical dysgeneses: microtubule dysfunction underlying neurobal migration defects. Trends Gen. 2009, 25:555-566.
22. Jalbout M., Bel Hadi Jrad B., Bouaouina N., Gargouri J., Yacoub S., Zakhama A., Khlifa R., Chouchane L. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int. J. Cancer 2002, 101:146-150.
23. Kang E.H., Shen G.Q., Morris R., Metzger A., Lee E.Y., Lee Y.E., Lee E.B., Song Y.W. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases. Lupus 2008, 17:21-25.
24. Kirvan C.A., Cox C.J., Swedo S.E., Cunningham M.W. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J. Immunol. 2007, 178:7412-7421.
25. Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 2003, 9:920.
26. Klein R., Richter C., Berg P.A. Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and Western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases. Autoimmunity 1991, 10:133-144.
27. Koutouzis T., Haber D., Shaddox L., Aukhil I., Wallet S.M. Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study. J. Periodontol. 2009, 80:625-633.
28. Laemmli U. Cleavage of structural proteins during assembly of the head of bacteriphage T4. Nature 1970, 277:680-685.
29. Margutti P., Sorice M., Conti F., Delunardo F., Racaniello M., Alessandri C., Siracusano A., Riganò R., Profumo E., Valesini G., Ortona E. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res. Ther. 2005, 7:R903.
30. Mondal T.K., Saha S.K., Miller V.M., Seegal R.F., Lawrence D.A. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus ub the NZM88 murine model. Brain Behav. Immun. 2008, 22:949-959.
31. Omdal R., Brokstad K., Waterloo K., Koldingsnes W., Jonsson R., Mellgren S.I. Neuropsychiatric disturbances in SLE are associated with Abs against NMDA receptors. Eur. J. Neurol. 2005, 12:392-398.
32. Perkins D.N., Creasy D.M., Cottrell J.S. An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Electrophoresis 1999, 20:3551-3567.
33. Poulain F.E., Sobel A. The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol. Cell. Neurosci. 2010, 43:15-32.
34. Preuss, B., Dengjel, J., Stevanovic, S., and Klein, R., 2009. Identification of the b- and g-subunits of F1-ATPase as target antigens in anti-M2/PDC-E2 negative primary biliary cirrhosis (PBC). Hepatology 50(Suppl. 4), 1000A.
35. Servettaz A., Guilpain P., Tamas N., Kaveri S.V., Camoin L., Mouthon L. Natural anti-endothelial cell antibodies. Autoimmun. Rev. 2008, 7:426-430.
36. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
37. Shukla S., Pranay A., D'Cruz A.K., Chaturvedi P., Kane S.V., Zingde S.M. Immunoproteomics reveal that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark. 2009, 5:127-135.
38. Sibbitt W.J., Sibbitt R., Brooks W. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999, 42:2026-2038.
39. Stanojcic M., Burstyn-Cohen T., Nashi N., Lemke G., Sakic B. Disturbed distribution of proliferative brain cells during lupus-like disease. Brain Behav. Immun. 2009, 23:1003-1013.
40. Svarcová J., Fialová L., Bartos A., Steinbachová M., Malbohan I. Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. Eur. J. Neurol. 2008, 15:1173-1179.
41. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
42. Towbin H., Staehelin H., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76:4350-4354.
43. Wade R.H. On and around microtubules: an overview. Mol. Biotechnol. 2009, 43:177-191.
44. Watanabe H., Seino T., Sato Y. Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus. Biochem. Biophys. Res. Commun. 2004, 321:949-953.
45. Weiner S.M., Otte A., Schumacher M., Klein R., Gutfleisch J., Brink I., Otto P., Nitzsche E.U., Moser E., Peter H.H. Diagnosis and monitoring of central nervous system involvement in sytemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann. Rheum. Dis. 2000, 59:377-385.
46. Williams R.C.Jr., Sugiura K., Tan E.M. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2004, 50:1239-1247.
47. Wolff J. Plasma membrane tubulin. Biochim. Biophys. Acta 2009, 1788:1415-1433.
48. Yoo T.J., Kwon S.S. Molecular mechanisms of autoimmune hearing loss. Acta Otolaryngol. Suppl. 2002, 548:3-9.
49. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 2007, 36:297-315.
50. Zhang X., Zhu Z., Zhang F., Shu H., Li F., Dang Y. Diagnostic value of single-photonemission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2005, 53:845-849.